KELSEYVILLE, CA, April 04, 2018 (GLOBE NEWSWIRE) -- Vet Online Supply, Inc. (OTC:VTNL) (the Company), announces today that its new line of CBD Pet Oral Sprays has landed its first wholesale distribution order for $6.5M.
Daniel Rushford, CEO and Chairman, stated “The Company started receiving orders for our new Oral Pet Sprays on March 26, 2018 and is now selling its CBD Pet Oral Sprays and anticipates the largest revenue stream from these two products as compared to our other CBD Pet Treats and Pet Drops. A major CBD wholesaler has agreed to purchase $6.5M on Oral Pet Sprays from Vet Online Supply Inc. during the next 12 months. Vet Online Supply is allowing the wholesaler an exclusive agreement to purchase and place our CBD Pet products in west coast based marijuana dispensaries through April 3, 2019.”
The company’s Pain & Joint Support Oral Pet Spray and our Anti-Stress & Calming Oral Pet Spray are available in an 8ml/.25 ounce concentrated formula spray bottle that is environmentally friendly. The retail cost for the oral sprays are $47.99 each and available at this time only through our online retail website.
ABOUT VET ONLINE SUPPLY:
Vet Online Supply Inc. is a small US based online retail reseller of proprietary veterinary products to enhance the pets health and well being. The goal of "Vet Online Supply" is to provide the $38B industry with value priced, superior quality holistic pet products.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.